BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21523793)

  • 1. Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.
    Abbasi M; Lavasanifar A; Uludag H
    Med Res Rev; 2013 Jan; 33(1):33-53. PubMed ID: 21523793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming multidrug resistance by RNA interference.
    Stege A; Krühn A; Lage H
    Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
    Stege A; Priebsch A; Nieth C; Lage H
    Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
    Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells.
    Lin G; Zhu W; Yang L; Wu J; Lin B; Xu Y; Cheng Z; Xia C; Gong Q; Song B; Ai H
    Biomaterials; 2014 Nov; 35(35):9495-507. PubMed ID: 25155545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversion effect of the RNAi-silencing mdr1 gene on multidrug resistance of the leukemia cell HT9.
    Shao SL; Sun YY; Li XY; Zhang WW; Fu B; Yun DZ; Zuo MX
    Cell Biol Int; 2008 Aug; 32(8):893-8. PubMed ID: 18499486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells.
    Abbasi M; Lavasanifar A; Berthiaume LG; Weinfeld M; Uludağ H
    Cancer; 2010 Dec; 116(23):5544-54. PubMed ID: 20715163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jet-injection of short hairpin RNA-encoding vectors into tumor cells.
    Walther W; Stein U; Lage H
    Methods Mol Biol; 2010; 629():123-39. PubMed ID: 20387147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
    Hua J; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.
    Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H
    Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking.
    Li JM; Wang YY; Zhao MX; Tan CP; Li YQ; Le XY; Ji LN; Mao ZW
    Biomaterials; 2012 Mar; 33(9):2780-90. PubMed ID: 22243797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB.
    Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH
    Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.